Next Article in Journal
Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial
Next Article in Special Issue
Pneumococcal Vaccination in Adults: A Narrative Review of Considerations for Individualized Decision-Making
Previous Article in Journal
Development and Assessment of Innovative High-Fidelity Simulation Vaccination Course Integrating Emergency Cases for Pharmacy Undergraduates—A Randomized Controlled Study
 
 
Review

Article Versions Notes

Vaccines 2023, 11(2), 325; https://doi.org/10.3390/vaccines11020325
Action Date Notes Link
article pdf uploaded. 31 January 2023 17:42 CET Version of Record https://www.mdpi.com/2076-393X/11/2/325/pdf-vor
article xml file uploaded 15 February 2023 08:59 CET Original file -
article xml uploaded. 15 February 2023 08:59 CET Update -
article pdf uploaded. 15 February 2023 08:59 CET Updated version of record https://www.mdpi.com/2076-393X/11/2/325/pdf-vor
article html file updated 15 February 2023 09:00 CET Original file -
article xml file uploaded 23 February 2023 01:53 CET Update -
article xml uploaded. 23 February 2023 01:53 CET Update https://www.mdpi.com/2076-393X/11/2/325/xml
article pdf uploaded. 23 February 2023 01:53 CET Updated version of record https://www.mdpi.com/2076-393X/11/2/325/pdf
article html file updated 23 February 2023 01:54 CET Update -
article html file updated 8 March 2023 20:54 CET Update https://www.mdpi.com/2076-393X/11/2/325/html
Back to TopTop